Use of sustained 4-aminopyridine release to improve neuro-cognitive and / or neuro-psychiatric impairment of patients with multiple sclerosis (MS)

摘要

A sustained release composition of 4-aminopyridine for use in a dosage method to improve at least one neurocognitive or neuropsychiatric parameter in a patient, in which the patient has multiple sclerosis.